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Introduction
Gestational diabetes (GDM) is traditionally defined as carbohydrate intolerance with its onset or first recognition in pregnancy, 1 although more recent definitions explicitly exclude pre-existing type 2 diabetes. 2 It is one of the most common adverse conditions of pregnancy. Its incidence has generally been reported to be rising in most populations, usually in line with the increasing prevalence of maternal obesity. 3 Other major risk factors for GDM include having a previous history of it or having previously given birth to a macrosomic baby, a family history of GDM and/or type 2 diabetes, increased maternal age, increased gestational weight gain, genetics, multiparity and ethnic factors, 4 not all of which can explain the tempo of the rising incidence. As GDM increases the risk of short-and longterm adverse complications for both the mother and her unborn child (including macrosomia, pre-eclampsia, childhood obesity and the metabolic syndrome in the mother 5 ) and may contribute to the diabetes pandemic 6 , a thorough understanding of its pathogenesis is essential.
With the apparent worldwide rise in the prevalence of GDM 7 paralleling the increasing prevalence of female obesity 8 of note are the temporal and potentially mechanistic links that obesity has with global warming. 9 Therefore another factor that could explain at least part of the increased incidence of GDM is exposure to raised or rising ambient temperatures in certain populations. [10] [11] [12] Following this some studies have reported seasonal variations in the incidence of GDM [13] [14] [15] [16] [17] , although this has not been observed in all populations or climates. 18, 19 In this study we investigated whether there were temporal and seasonal trends in GDM incidence in our single centre population from Cambridge, U.K. which recruited pregnant women between 2001 and 2009. We then investigated what may have Petry et al., mediated any trends. Although relating to a decade ago this seemed reasonable given that GDM was already becoming more prevalent by this time in several different populations. [20] [21] [22] [23] [24] [25] 
Materials and Methods

Cambridge Baby Growth Study
The prospective, longitudinal Cambridge Baby Growth Study (CBGS) was established as an observational cohort initially covering pregnancy, birth and infancy. 26 
Oral Glucose Tolerance Test and Gestational Diabetes Diagnostic Criteria
At a median (inter-quartile range) of 28.4 (28.1-28.7) weeks gestation 1,074 of the CBGS mothers underwent a 75g oral glucose tolerance test (OGTT) after fasting overnight. 27 Venous blood was collected just prior to and 60 min. after the glucose load was administered for the measurement of plasma glucose, insulin and c-peptide concentrations. 
Assays
All biochemical kit-based assays were run according to the manufacturer's instructions.
Glucose concentrations were measured using a routine glucose oxidase-based method.
OGTT plasma insulin concentrations were measured by ELISA (Dako UK Ltd., Ely, Cambs, 
Calculations
The maternal body mass index (BMI) was calculated as the pre-pregnancy weight divided by the height squared. Insulin sensitivity and pancreatic β-cell function were estimated using the homeostasis model assessment (HOMA S and B, respectively), calculated using the week 28 fasting circulating glucose and insulin (or c-peptide) concentrations and the online HOMA2 calculator (available at https://www.dtu.ox.ac.uk/homacalculator/). 30 
Statistical Analysis
The present analysis was restricted to those 1,074 pregnancies where the women 
Results
Characteristics of the Study Population
With the exception of a slight increase in parity and a reduced proportion of smokers, those women who were included in the analysis were representative of the Cambridge Baby
Growth Study as a whole ( 
Temporal Trends of GDM Incidence and OGTT Glucose Concentrations
The overall prevalence of GDM in this population was 10.1% (108/1,071). Cosinor analysis showed a significant temporal effect associated with the year of analysis (0.014 (0.005, 0.022) proportional increase per year, p=2.1x10 -3 ), with a trend for the incidence of GDM increasing through the years 2001-9 ( Fig. 1 ). This finding was confirmed by logistic regression (odds ratio (OR) 1. 
Associations of the Year of Analysis with Potential Risk Factors
The year of analysis was not associated with either the maternal BMI (β'=0.006, p=0.9, n=827) or pregnancy weight gain (β'=-0.047, p=0.2, n=614). Neither was it associated with maternal age (β'=-0.016, p=0.6, n=898) or parity (β'=0.007, p=0.8, n=1,022) in this population. There was no association between the year of analysis and the proportion of male babies (χ 2 =4.9, p=0.8, n=1,024), birth weight of the babies (β'=-0.023, p=0.4, n=824;
adjusted for gestational age at birth, mother's BMI, parity and sex) or the odds of a pregnancy being multifetal (OR 1.0 (0.9, 1.2), p=0.9, n=1,071). One potential confounder that year of analysis was modestly albeit highly significantly associated with, the index of multiple deprivation (p=4.6x10 -10 , n=1,068) ( Fig. 3) , was itself not directly associated with GDM (OR 1.0 (1.0, 1.1) per unit increase in the index, p=0.6, n=1,032). There was still a significant relationship between the index of multiple deprivation and the year in the reduced number of 955 women for whom HOMA modelling was available (p=5.2x10 -8 ). In these women the index of multiple deprivation was significantly positively associated with HOMA B (p=6.1x10 -5 ; Fig. 3 ) but not with HOMA S (p=0.2) or the insulin disposition index (p=0.4).
Discussion
In this analysis there was a strong trend for the incidence of GDM increasing as recruitment to the cohort progressed between 2001 and 2009. Trends over a similar period of time have also been observed in populations in Canada 21 , the U.S.A. 22, 24 , Israel 23 and Germany 25 . The worldwide increased incidence at that time appeared to be independent of ethnicity 20 despite this being a major factor associated with GDM risk. 4 In our population the increased incidence of GDM was associated with reductions in HOMA B and the insulin disposition index (rather than HOMA S). Whilst a temporal trend in these factors could relate to changes in the performance of the insulin and glucose assays that were used over time, we used the same assays for these analytes throughout this time period and the performance Petry et al., characteristics of the insulin assay matched those of similar assays available at the time. 32 Given that the performance of the glucose assay did not change over this time, the fact that the associations with HOMA B and the disposition index persisted if they were calculated using c-peptide rather than insulin concentrations suggests that these associations were physiological rather than assay-related. The temporal increase in GDM incidence in our population therefore appeared to relate to reductions in insulin secretion rather than sensitivity (indeed insulin-derived HOMA S actually increased over the period of recruitment, albeit this association was not evident when c-peptide concentrations were used to calculate HOMA S in a smaller number of women).
The temporal increase in GDM incidence was clearly environmentally-mediated as its tempo was too fast for a genetic change. In investigating its potential causes and the reduced insulin secretion we could not find parallel increases in BMI, pregnancy weight gain, maternal age or smoking. There was, however, a significant temporal trend of increasing deprivation in the study (in a population that was generally less-deprived than the national average 26 ) although deprivation itself was not associated with GDM. There was a modest albeit highly significant positive association between the index of multiple deprivation and insulin-derived HOMA B. This suggests that, in the absence of a direct associations with HOMA S or GDM risk, as the deprivation index went up pancreatic β-cell function might have had to increase slightly to maintain glucose homeostasis. Due to the lack of direct association between the deprivation index and GDM despite the temporal trend, it is possible however that as yet unidentified confounder(s) related to deprivation, such as factors connected with diet 33 and/or exercise 34 , could have contributed to the temporal increase in GDM incidence. This would be consistent with studies where associations between GDM and deprivation, lower socioeconomic status or lower social class were reported 25, 35, 36 although such associations have not been found in every study. 37 An alternative explanation for the temporal trend in deprivation in the present study is that it may just reflect unintentional secular patterning in study recruitment or uptake.
Although we observed a temporal trend of increasing GDM incidence as the decade progressed in this analysis we could not find a seasonal trend. This is despite seasonal trends in GDM previously have been observed in populations in Sweden 13 , Australia 14, 15 , Italy 16 and Greece 17 . However of the populations tested before where no such trend was observed 18, 19 one of these was also in the U.K. 19 so our lack of seasonal trend may relate to climate or other environmental factors specific to the U.K. Alternatively, whilst at least one of the studies that found a seasonal trend used a very similar analysis technique to the one that we used 15 , other studies used analysis of variance or categorical/ordinal analyses which did not account for the recurring nature of the seasons or adjust for longer-term temporal trends 13, 14, 16, 17 so differences from our results may relate to this.
The strengths of our prospective study include the fact that we used cosinor analysis to adjust linear temporal trends for separate potential seasonal effects, unlike some of the other studies in this area. In addition we had third trimester OGTT data from all the study participants and so we were able to investigate whether temporal trends in GDM incidence were related to changes in insulin sensitivity or secretion. We calculated HOMAs using both insulin and c-peptide concentrations so that detectable temporal trends were less likely to have resulted from drift in assay performance. In addition to its strengths the study does have a number of limitations however. Firstly this Cambridge cohort may not fully reflect the U.K. population as a whole particularly in relation to ethnic mix and smoking prevalence 25 , although this means that there was probably less confounding due to ethnic effects. Secondly we did not record family histories of GDM and type 2 diabetes, major risk factors for GDM. 4 Thirdly although the study was fairly large given the level of detail that was collected, it was smaller than temporal studies of large surveys (e.g. 38 ) and therefore our trends were estimated with less precision than is possible in that kind of study. This could partially account for the large magnitude of the increased GDM incidence over the course of the recruitment period in our study. Finally the insulin (and c-peptide) disposition index was not calculated using 30 min. OGTT glucose and insulin concentrations like usual, but using 60 min. concentrations instead. Although comparing OGTT results from our study with those more commonly from intravenous GTTs, its use has been deemed acceptable at least for the insulinogenic element of the disposition index. 39 In conclusion we observed a temporal but not seasonal trend for an increasing incidence of GDM in Cambridge Baby Growth Study pregnancies from the years 2001-2009. This was associated with reductions in indices of insulin secretion rather than insulin sensitivity.
Although we do not know what caused these changes it does not appear to relate to changes in maternal obesity or age. Factors relating to deprivation offer potential explanations. *adjusted for maternal pre-pregnancy BMI, gestational age at birth, sex of baby and parity.
Data are either number of participants or mean (95% confidence interval). 
